3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Breast Neoplasms
3
Brain Neoplasms
2
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Non-alcoholic Fatty Liver Disease
1
Multiple Myeloma
1
Intermittent Fasting
1
Fatty Liver
1
Estrogen Receptor-positive Breast Cancer
1
Endometrial Neoplasms
1
Drug Resistant Epilepsy
1
Autism Spectrum Disorder
1
Adenocarcinoma of Lung
1
Interventions
Nivolumab
70
pembrolizumab
69
cabozantinib
46
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Diet, Ketogenic
×
1 year
×
Clear all
No trials found.